Evofem Biosciences, Inc. Quarterly Common Stock, Shares, Issued from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Evofem Biosciences, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q2 2024.
  • Evofem Biosciences, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 82.8M shares, a 3181% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 82.8M +80.3M +3181% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 48.7M +47M +2719% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 20M +19M +1932% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 5.68M -96.3M -94.4% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 2.52M -76.5M -96.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 1.73M -10.6M -86% Mar 31, 2023 10-Q 2023-06-16
Q4 2022 985K -9.85M -90.9% Dec 31, 2022 10-K 2024-03-27
Q3 2022 102M -53.2M -34.3% Sep 30, 2022 10-Q 2023-01-06
Q2 2022 79.1M -76.1M -49% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 12.3M -87.9M -87.7% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 10.8M -70.5M -86.7% Dec 31, 2021 10-K 2023-04-27
Q3 2021 155M +73.9M +91% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 155M +73.8M +90.8% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 100M +50.6M +102% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 81.4M +33.2M +69% Dec 31, 2020 10-K 2022-03-10
Q3 2020 81.3M +34.5M +73.7% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 81.3M +34.9M +75.1% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 49.6M +20.9M +72.9% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 48.1M +22.3M +86.1% Dec 31, 2019 10-K 2021-03-04
Q3 2019 46.8M +20.9M +80.8% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 46.4M +21.2M +84.2% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 28.7M +10.9M +61.6% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 25.9M +23.8M +1142% Dec 31, 2018 10-K 2020-03-12
Q3 2018 25.9M +12.1M +87.1% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 25.2M +11.4M +82.2% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 17.8M +3.93M +28.4% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 2.08M -79M -97.4% Dec 31, 2017 10-K 2019-03-01
Q3 2017 13.8M +3.25K +0.02% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 13.8M +16.2K +0.12% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 13.8M +32.6K +0.24% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 81.1M +67.4M +490% Dec 31, 2016 8-K/A 2018-04-06
Q3 2016 13.8M +121K +0.88% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 13.8M +125K +0.91% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 13.8M +128K +0.94% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 13.8M +78.7K +0.58% Dec 31, 2015 10-K 2017-03-23
Q3 2015 13.7M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 13.7M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 13.7M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 13.7M Dec 31, 2014 10-K 2016-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.